Pfizer Inc. et al v. Breckenridge Pharmaceutical, Inc.
PF PRISM IMB B.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc. and PF PRISM C.V. |
Breckenridge Pharmaceutical, Inc. |
1:2024cv01122 |
October 9, 2024 |
U.S. District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on November 13, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 10 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (Attachments: #1 Notice of Dismissal) (kmd) |
Filing 9 NOTICE of Voluntary Dismissal by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PBG Puerto Rico LLC, PF PRISM IMB B.V. as to Breckenridge Pharmaceutical, Inc. (Dellinger, Megan) |
CASE CLOSED per #9 Notice of Dismissal. (kmd) |
Filing 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Filing 7 WAIVER OF SERVICE returned executed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM IMB B.V., PF PRISM C.V.: For Breckenridge Pharmaceutical, Inc. waiver sent on 10/10/2024, answer due 12/9/2024. (Dellinger, Megan) |
Filing 6 Summons Issued as to Breckenridge Pharmaceutical, Inc. on 10/9/2024. (mpb) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (mpb) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (mpb) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/27/2024. Date of Expiration of Patent: 12/8/2025.Thirty Month Stay Deadline: Upon Expiration of the patent (mpb) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Breckenridge Pharmaceutical, Inc. ( Filing fee $ 405, receipt number ADEDC-4519927.) - filed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM IMB B.V., PF PRISM C.V.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.